Why BRCA matters for men, not just women
BRCA1 and BRCA2 are tumor suppressor genes. MedlinePlus Genetics explains that they help repair damaged DNA, and harmful changes in them let errors build up that can lead to cancer. Most people know them from breast and ovarian cancer in women, but men can carry and pass on these variants too, and a male carrier faces real risks of his own.
The National Cancer Institute gives these estimates for men:
| Cancer | General population | BRCA1 variant | BRCA2 variant |
|---|---|---|---|
| Male breast cancer, by age 70 | About 0.1% | 0.2% to 1.2% | 1.8% to 7.1% |
| Prostate cancer, by age 80 | About 10.6% | 7% to 26% | 19% to 61% |
| Pancreatic cancer, lifetime | About 1.7% | Up to 5% | 5% to 10% |
BRCA2 carries the larger risk for men. A positive result also matters for your family, since each of your children, sons and daughters alike, could have inherited the same change.
Who should consider adding the BRCA screen
BRCA testing is most useful when it is aimed at families with a reason to look. The NCI lists these signs that a man is more likely to carry a harmful change:
- A relative who has already tested positive for a BRCA variant
- Ashkenazi Jewish ancestry
- Breast cancer in a relative diagnosed at 50 or younger
- Ovarian, pancreatic or male breast cancer anywhere in the family
- Metastatic or high-risk prostate cancer in you or a relative
If you are worried mainly because a father or brother had prostate cancer, read our page on family history of prostate cancer, which explains how that history changes screening even without a gene test. Men with no family history who want reassurance should know the test is unlikely to find anything and may return a confusing uncertain result.
Before the call, gather what you can: which relatives had cancer, what type, their age at diagnosis, and whether anyone has already had genetic testing. A copy of a relative’s positive report is especially valuable, because it tells the lab exactly which change to look for.
How a positive result changes PSA and cancer screening
For an average-risk man, the U.S. Preventive Services Task Force frames PSA screening between 55 and 69 as an individual decision. A BRCA variant changes that picture.
The 2023 AUA/SUO prostate screening guideline recommends offering screening beginning at age 40 to 45 for people at increased risk, a group that includes carriers of germline mutations. It cites data showing an eight-fold higher risk of aggressive prostate cancer in BRCA2 carriers, while noting that the role of screening for BRCA1 carriers needs more study.
| Area | Average-risk man | Man with a BRCA variant (to discuss with specialists) |
|---|---|---|
| PSA screening | Shared decision, mainly 55 to 69 | Offered from 40 to 45, often more frequently, especially for BRCA2 |
| Breast | No routine screening | Breast checks and imaging discussed, particularly for BRCA2 |
| Pancreas | No routine screening | Imaging discussed if a close relative had pancreatic cancer |
The NCI notes that some guidelines recommend yearly prostate and breast screening for male carriers, especially those with BRCA2. Our guides to the PSA blood test and when to start PSA screening explain how the test itself works.
Understanding positive, negative and uncertain results
There are three kinds of result. A positive result means a harmful variant was found and your risk is higher, but the NCI is clear that it cannot tell whether or when you will develop cancer. A negative result is most useful when a relative’s known variant was specifically ruled out. A variant of uncertain significance means the lab found a change it cannot yet classify, and until it is reclassified, screening follows your family history.
That nuance is why the NCI recommends talking with a genetic counselor, ideally before testing and certainly after a positive or uncertain result. It is also worth knowing your legal protections. The Genetic Information Nondiscrimination Act covers health insurance and employment at companies with 15 or more workers, but not life, disability or long-term care insurance.
How BRCA testing works at Ultimate Male
BRCA screening is an optional add-on to the clinic’s genetic risk screening panel, offered based on family history or personal health concerns. The blood draw is the same quick, on-site draw used for every panel at San Gabriel and Downey, and genetic results take longer to come back than standard labs.
The clinic has not published which laboratory runs the test, how much of each gene it analyzes, whether genetic counseling is included or how long results take. Ask about all four on the free call. Those details decide how much a result can tell you, so get them answered before you pay. Our answer on the genetic risk panel for men covers related questions.
If your result is positive or uncertain, the review with your PA-C or MD covers what it means and why a genetic counselor and the right specialists, such as a urologist, should be part of your care from there.
Paying for BRCA testing
Ultimate Male is direct-pay, does not bill insurance and does not publish lab prices; you get a quote before the draw. Lab testing is FSA and HSA eligible with an itemized receipt. If you meet the family history criteria above, check whether your health plan would cover testing through another provider before paying out of pocket, and see our genetic risk screening cost page for what affects the price.
To talk through whether BRCA testing fits your family history, call 626-319-5261 for a free 10-minute conversation, or explore our other preventative blood testing options.
